The Corporate Prescription: Analyzing the Impact and Legal Fallout of the Corporatization of Healthcare

The healthcare sector has undergone a profound transformation with the rise of corporate-driven models and the increasing financialization of medical services. Historically rooted in holistic, patient-centered care, modern healthcare delivery now faces a complex interplay between patient welfare, profit motives, and market-driven reforms. This paper examines the historical evolution of patient-centered care, the emergence of corporate healthcare structures, and the impact of financialization on quality, access, and trust. It identifies critical gaps in existing legal and regulatory frameworks governing corporate medical practices. This paper explores: (1) historical background and definition of patient-centered care and financialization, (2) existing legal frameworks and regulatory responses, (3) legal gaps, dilemmas, and liability issues, and (4) potential solutions and adaptation strategies. Methodologically, the analysis synthesizes historical data, comparative case studies, and international legal instruments. The findings suggest that current regulations insufficiently address the conflicts of interest inherent in corporate healthcare and the systemic risks posed by financialized models. The conclusion recommends targeted treaty reforms, stronger accountability mechanisms, and increased emphasis on patient rights to restore balance between market forces and public health goals. Future implications include potential cross-border policy harmonization to safeguard healthcare equity and sustainability.